EYA1 stimulated the activity of Cyclin D1, and EYA2 inhibited the transcriptional activity of the ER-β by dephosphorylating the Y36 residue, thus promoting cancer cellular proliferation and tumor growth [88, 89]. Here, EYA2 is linked to neoplasm.